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Abstract 
Objective: During Intra-Aortic Balloon (IAB) inflation, blood volume is displaced towards the heart 
(Vtip), traveling retrograde in the descending aorta, passing by the arch vessels, reaching the aortic 
root (Vroot) and eventually perfusing the coronary circulation (Vcor). Vcor leads to coronary flow 
augmentation, one of the main benefits of IAB pumping. The aim of this study was to assess Vroot and 
Vcor in vivo and in vitro, respectively. 
Methods: During IAB inflation, Vroot was obtained by integrating over time the aortic root flow 
signals measured in 10 patients with IAB assistance frequency 1:1 and 1:2. In a mock circulation 
system, flow measurements were recorded simultaneously upstream the IAB tip and at each of the 
arch and coronary branches of a silicone aorta during 1:1 and 1:2 IAB support. Integration over time 
of the flow signals during inflation yielded Vcor and the distribution of Vtip. 
Results: In patients, Vroot was 6.4 ± 4.8% of the IAB volume during 1:1 and 10.0 ± 5.0% during 1:2. 
In vitro and with an artificial heart simulating the native heart, Vcor was smaller, 3.7% and 3.8%, 
respectively. The distribution of Vtip in vitro varied, with less volume displaced towards the arch and 
coronary branches and more volume stored in the compliant aortic wall when the artificial heart was 
not operating. 
Conclusions: The blood volume displaced towards the coronary circulation due to IAB inflation is a 
small percentage of the nominal IAB volume. Although small, this percentage is still a significant 
fraction of baseline coronary flow. 
 
Ultramini-Abstract 
The blood volume displaced towards the coronary circulation during Intra-Aortic Balloon (IAB) 
inflation was assessed in vivo and in vitro. This volume was approximately 5% of the nominal volume 
of the IAB. Although small, this volume can provide significant augmentation in baseline coronary 
flow. 
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Introduction 
The Intra-Aortic Balloon Pump (IABP) provides mechanical support to the heart, both in the surgical 
setting pre-, post- and intra-operatively and in the medical setting in clinical conditions such as 
cardiogenic shock, myocardial infarction or unstable angina (1-5). It is also often used as a bridge to 
cardiac transplantation (4, 6). 
The balloon (IAB) starts to inflate immediately after left ventricular (LV) ejection and completes 
deflation before the onset of the following LV ejection. Accurate timing is essential for optimum 
IABP performance. 
When the IAB is inflated it displaces blood volume upstream, towards the heart, producing an 
increase in early-diastolic aortic pressure and providing a boost to coronary blood supply. Similarly, 
when the IAB is deflated it draws blood volume downstream, away from the heart, reducing end-
diastolic aortic pressure and thus LV afterload. Other beneficial effects related to these major 
outcomes are decrease in LV volume and LV systolic work, reduction in end-diastolic and peak-
systolic aortic pressure, increased stroke volume and improved cardiac output (4). 
In this study we focused on the phase of IAB inflation and more specifically on the blood volume 
displaced towards the coronary circulation during inflation. In vivo studies report increased peak 
diastolic and mean coronary flow velocity, and increased diastolic coronary flow velocity integral in 
healthy coronary vessels (3, 7-10), but reports on the blood volume flowing through the coronary 
arteries due to inflation (Vcor) are scarce. A microsphere study in sheep reports Vcor of 0.1 ml/min/g in 
myocardial tissue supplied by a non-stenotic artery (11), but there are no comparable data in humans.  
The IAB is placed in the descending aorta, between the arch vessels and the renal arteries. During 
IAB inflation blood volume is displaced upstream the IAB tip (Vtip), travels retrograde in the 
descending aorta, passes by the arch vessels, travels into the ascending aorta, arrives at the aortic root 
(Vroot) and eventually is directed into the coronary circulation as Vcor. Neither Vroot or Vcor nor their 
relation to Vtip is adequately reported in the literature. Accordingly, the aim of this study is to measure 
Vroot in humans, as an indication of the volume pushed towards the coronary arteries due to IAB 
inflation. A more detailed in vitro study in a mock circulation was also conducted, where the 
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distribution of Vtip in the aortic arch, the coronary branches and the compliant aortic wall was 
quantified. 
 
Methods 
In vivo data 
The study population consisted of 10 patients (7 males; mean age 56 ± 5 yr) who were supported by 
the IABP at least two days prior open-chest surgery for VAD placement . The protocol was approved 
by the Human Subjects Protection Program Office of the University of Louisville and written 
informed consent was obtained from all patients. 
IAB catheters (Datascope, NJ, USA) with a balloon size of 34 or 40 cc were inserted via the femoral 
artery and connected to the IABP (System 98 or CS100, Datascope).  
The patients were anaesthetized according to a routine protocol and anaesthesia was maintained with 
Isoflurane. 
Simultaneous aortic (Pao) and left ventricular (PLV) pressure signals were recorded with a high fidelity 
5F dual-pressure-sensor catheter (Millar Instruments, TX, USA). Flow (Qao) was measured at the 
same location as Pao with a perivascular flow probe (Transonic Systems Inc, NY, USA). Pao and Qao 
were obtained at the aortic root, distal to the coronary arteries. Hemodynamic data and the ECG were 
recorded at 200 or 400Hz. 
In all patients, data were recorded prior to VAD placement with IABP assistance frequency of 1:1, 1:2 
and also when the pump was on standby. Timing of inflation and deflation was based on the aortic 
pressure signal recorded internally by the pump with the fluid-filled catheter incorporated in the IAB. 
For each pump setting, data were collected continuously for approximately 15 s and a few minutes 
were allowed between successive measurements for hemodynamics to stabilize. 
For each patient a single representative beat was selected for each condition. Figure 1 shows typical 
examples of Pao and Qao recordings during a control and its following assisted beat from a 63 (Figure 
1A) and a 60 yr old male patient (Figure 1B). As can be deduced from the onset of the rapid increase 
in Pao during early-diastole with respect to the incisura, Figure 1A corresponds to a case of well-timed 
inflation, whereas Figure 1B illustrates a case of fortuitous late inflation. 
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From the aortic root flow measurements, Vroot was calculated by integrating over time the negative 
peak during IAB inflation, as shown in Figure 1. Vroot was normalized with respect to IAB volume, in 
order to render results between patients assisted with different IAB sizes, comparable. 
Averages per beat were calculated for Pao, Qao and systolic PLV. 
In vitro data 
A physiological distribution of resistance and compliance was applied across a silicone aortic model 
(Ranier, Cambridge, UK) with 14 main branches (left and right coronary, left and right carotid, left 
and right subclavian, celiac, splenic, left and right renal, left and right femoral, and left and right deep 
femoral). Realistic values for terminal resistance and compliance of each branch were obtained from 
the model described by Stergiopulos et al. (12), after reducing their 55-branch model to 14 branches 
by summing resistances and compliances according to basic in parallel and in series electrical circuit 
concepts. Flow out of each branch was directed to a common drainage tube and was connected to an 
overhead water reservoir providing a head pressure of 10 mm Hg in the silicone model. 
An extracorporeal left ventricular assist device (BVS5000, Abiomed Inc, MA, USA) was used to 
simulate the native heart in vitro. It was driven with water by a piston pump (Placepower, Norfolk, 
UK) and provided a cardiac output of 2.7 l/min at a heart rate of 60 bpm, working close to its 
maximum capacity. The ‘left ventricle’ of the artificial heart was connected to the ‘aortic root’ of the 
aortic model and the ‘left atrium’ to the overhead reservoir. The IABP was triggered by the piston 
pump. 
Intra-aortic balloons (Datascope) with size of 25 and 40 cc were inserted via the ‘left common 
femoral’ branch, advanced into the aorta until their tips were just distal to the subclavian branch and 
connected to the IABP (System 97e, Datascope). 
‘Aortic’ pressure (Ptip) at the tip of the IAB was recorded with a solid-state 7F sensor-tipped catheter 
(Gaeltec Ltd, Isle of Skye, UK). Flows (Q) at the tip of the IAB (Qtip) and through the ‘carotid’, 
‘subclavian’ and ‘coronary’ branches were measured with 20, 10, 8 and 3 mm flowprobes 
respectively (Transonic Systems Inc). Data were digitized and recorded at 500Hz using a LabView-
based acquisition system. 
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In order to assess the effect of the IAB inflation separately from the combined effect of IAB inflation 
and diastolic recoiling of the aorta, recordings were made with the IABP operating in 1:1 and 1:2 with 
and without the artificial heart. When the balloon was simply pumping against standstill conditions, 
the IABP was driven by a patient simulator (System 90 Series IABP Trainer, Datascope) which was 
set at a heart rate of 60 bpm. Steady-state intra-aortic pressure was 66 mm Hg, to simulate mean 
diastolic pressure in patients.  
Multiple beats were analyzed for each condition. Figure 2 shows typical examples of Ptip and Qtip 
recordings during 1:2 assistance, without (top) and with the artificial heart (bottom) for a control and 
its following assisted beat. 
The coronary, subclavian and carotid Q measurements and Qtip were integrated with respect to time as 
shown in Figure 2 (for Qtip), in order to derive the blood volume (V) displaced through the respective 
branches and upstream the IAB tip, due to inflation. By subtracting Vtip from the nominal balloon 
volume we derived an approximation of the volume displaced downstream. The volume displaced 
upstream from the IAB tip, Vtip, without going through the coronary or the arch branches is stored in 
the compliant aortic wall and is referred to as Vcompliance. 
Statistical analysis 
Data are expressed as mean ± SD. Statistical significance was assumed at P<0.05. 
For the in vivo data, results between assistance frequencies 1:1, 1:2 and pump off were compared with 
ANOVA with repeated measures, followed by contrast analysis (SPSS v 15.0, IL, USA). Due to the 
small patient population, a more elaborate statistical analysis taking into account possible interactions 
from factors such as balloon size, could not be performed. 
For the in vitro data, statistical comparisons were only made with and without the artificial heart, for 
each balloon size and assistance frequency, with unpaired t-tests. Comparisons between the assistance 
frequencies or the balloon sizes were not considered to be of important clinical information and were 
not performed. 
 
Results 
In vivo results 
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Hemodynamic signals 
Diastolic aortic pressure augmentation during inflation was demonstrated by a steep rise in the Pao 
signal of the assisted beat (Figure 1) and coincided with a negative peak in Qao, induced by blood 
volume displacement towards the aortic root. This peak was either overlapping with aortic retrograde 
flow (Figure 1A), or followed immediately after, as a distinct second negative peak (Figure 1B).  
Volume displacement 
During 1:1 assistance, Vroot was 6.4 ± 4.8% of the IAB volume and increased to 10.0 ± 5.0% during 
1:2, but the difference between the two assistance frequencies was not statistically significant (P = 
0.16). 
Hemodynamic parameters 
With 1:1 assistance, mean aortic pressure increased by 11.2% (61.6 ± 16.5 vs 68.5 ± 16.4 mm Hg, 
P<0.005). The increase was 20.2% with 1:2 assistance (58.8 ± 17.1 vs 70.7 ± 17.9 mm Hg, P<0.0001) 
and it was significantly higher with respect to 1:1 (P<0.05). Mean systolic LV pressure significantly 
decreased during 1:1 assistance by 8.7% (76.6 ± 21.0 vs 69.9 ± 19.8 mm Hg, P<0.0005) and similarly 
during 1:2 there was a decrease of 4.6% (73.8 ± 22.6 vs 70.4 ± 20.7 mm Hg, P<0.05). Mean aortic 
flow increased significantly during 1:1 by 26.4% (2.92 ± 1.06 vs 3.69 ± 1.29 l/min, P<0.01) and by 
13.0% (2.99 ± 1.27 vs 3.38 ± 1.25 l/min, P<0.05) during 1:2. 
In vitro results 
Hemodynamic signals 
Early-diastolic pressure augmentation was evident in the Ptip recording (Figure 2B) during IAB 
inflation, similarly to Figure 1. The same finding can also be observed in Figure 2A, but with no heart 
function. Both with and without the artificial heart, inflation was accompanied by a peak in Qtip which 
was caused by fluid volume displacement towards the aortic root. 
Volume displacement 
Figure 3 illustrates the percent distribution of IAB-induced flow during inflation in the coronaries, 
carotids, subclavians, compliant aortic wall and downstream the balloon, without (top) and with 
(bottom) heart function simulated by the artificial heart. The results correspond to a 25 cc IAB at 
assistance frequency 1:2. Overall, when the balloon was counterpulsating with the artificial heart, less 
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fluid volume was stored in the compliant aortic wall (5.3 ml vs 11.1 ml) and more was displaced 
downstream the balloon (10.4 ml vs 7.9 ml) and overall through the arch and coronary branches (9.3 
ml vs 6.0 ml). The volume displaced through both left and right coronary branches was 1.0 ml without 
and 0.9 ml with the artificial heart.  
Figure 4 presents the volume distribution in ml for a 40 cc balloon during 1:1 IABP support without 
and with heart function simulation. Similarly to the findings illustrated in Figure 3, with the artificial 
heart less fluid volume was stored in the compliant aortic wall (14.0 ml vs 21.8 ml) and more was 
displaced downstream the balloon (13.8 ml vs 9.8 ml) and through the arch and coronary branches 
(12.2 ml vs 8.4 ml). The total volume displaced through the coronary branches was 1.8 ml as opposed 
to 1.5 ml without the artificial heart. 
Qualitatively, these findings remained consistent between different balloon sizes and different 
assistance frequencies (Table 1). 
 
Discussion 
This study shows that the blood volume displaced in vivo towards the coronary circulation during IAB 
inflation is no more than 10% of the nominal balloon volume. These results are in agreement with our 
in vitro data, which demonstrate that the fluid volume that passes through the coronary branches 
during inflation is less than 5% of the IAB volume. The in vitro investigation further revealed that a 
large percentage of the fluid volume displaced upstream the IAB tip during inflation is stored in the 
compliant aortic wall. This percentage was almost two times higher when the artificial heart was not 
used for simulating the native heart function. 
Both the in vivo and in vitro results show that Vroot and Vcor, respectively, are only a small fraction of 
the total balloon volume, with the rest of Vtip being distributed between the arch branches and stored 
in the compliant aortic wall. In humans Vroot was 6.4% during 1:1 and 10.0 % with 1:2 IABP support. 
In vitro and with the artificial heart simulating heart function Vcor was even smaller, 3.7% and 3.8%, 
respectively. 
Augmentation of coronary perfusion during inflation 
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Even though Vroot in vivo and Vcor in vitro are small, an additional blood volume of 1-2 ml in the 
coronary circulation is a significant increase to baseline coronary blood flow (CBF). In humans with 
healthy coronary vessels, mean CBF of 200 ml/min and heart rate of 75 bpm (13), provide 
approximately 2.5 ml of blood to perfuse the coronary circulation during each heart cycle. Therefore 
an augmentation of 1-2 ml due to the IABP represents a significant increase in CBF. 
The increase of coronary flow in vitro in the experiment without the artificial heart simulated the 
clinical setting during cardiopulmonary bypass and aortic clamping.  The results suggest that IABP 
assistance also may have a role to play in CABG patients to improve coronary perfusion in the 
immediate postoperative period, when the heart is stunned after cardioplegia, CPB and the consequent 
inflammatory cascade. 
Augmentation of coronary perfusion during IABP support has been quantified in a microsphere study 
in sheep (11). The authors measured myocardial perfusion using microspheres, in myocardial regions 
supplied by an obstructed artery or by normal vessels in sheep. Measurements were taken at control 
conditions and during IABP counterpulsation with a 40 cc IAB. In the regions supplied by healthy 
coronary vessels, CBF was 0.55 ml/min/g at control and 0.65 ml/min/g during counterpulsation. For 
an average heart weight of 300 g, coronary perfusion would therefore be 2.75 ml at baseline and 3.25 
ml with IABP support. Despite the differences in the experimental settings which make a direct 
quantitative comparison of these results with ours difficult, both studies are in agreement in that the 
percentage of IAB volume that reaches the coronary circulation is small and in that this small 
percentage is however a large contribution to baseline coronary perfusion. 
Our in vitro measurements were obtained in unobstructed branches and it would therefore be rather 
difficult to extrapolate the above observations to stenotic coronary vessels. In the presence of a 
stenosis the effect of the IABP on CBF depends on the severity of the stenosis; the more severe the 
stenosis the smaller the augmentation in coronary perfusion, with the potential of even a reduction in 
CBF in cases of severe stenoses (7, 14-17). 
Vtip has been quantified in vitro in a straight latex tube for different IAB sizes and it was 
approximately 57% of the nominal balloon volume (18). Head pressure was 24 mm Hg and the IAB 
Upstream IAB volume in vitro 
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was operated from standstill. Considering the different experimental settings, these results are not 
substantially different from those of the present study, where Vtip was 72.6% at 1:1 and 68.1% at 1:2 
without the artificial heart, and 63.1% and 62.0%, respectively, with the artificial heart. 
It was not possible in the in vitro experiments to determine the distribution of stored volume along the 
compliant aortic wall, but, merely due to size, it can be speculated that the larger storage capacity lies 
in the upper aorta, in the portion upstream from the IAB tip. The length of this segment in the silicone 
aorta was 17 cm, with an average diameter of 24 mm. Measurements with ultrasonic crystals of the 
diameter of the upper descending sheep aorta during IAB counterpulsation, showed an increase of 
4.4% between systolic diameter and maximum diastolic diameter during inflation (19). An increase of 
4.4% in the mean diameter of the 17 cm segment of the silicone aorta can be translated to an increase 
of 6.5 ml of its total volume capacity during inflation. This volume is not dissimilar to the results of 
our in vitro study, showing volumes of 5.79 ml during 1:1 and of 5.29 ml during 1:2 assistance stored 
in the compliant aortic wall during the inflation of a 25 cc IAB. The corresponding volumes for a 40 
cc IAB are larger, most likely because the aortic model was overstretched during IAB inflation, in a 
way that would have been prevented in vivo by using a smaller IAB size. 
Volume storage in the aorta in vitro 
When the IAB was counterpulsating with the artificial heart, Vtip was smaller than when operating 
without the artificial heart. However, overall more volume was distributed to the arch and coronary 
branches and less was stored in the compliant aortic wall. This effect is clearly demonstrated in 
Figures 3 and 4 and in Table 1. 
Effect of heart function on IAB counterpulsation 
Since in both in vitro setups there is minimal diastolic or no flow in the aorta during IAB inflation, 
this difference in volume distribution can be associated with a difference in compliance (4). When 
IAB inflation follows a cardiac systole, due to the Windkessel effect taking place in the aorta during 
diastole, the elastic aortic wall will be recoiling at the same time the inflating balloon is trying to 
expand it. Due to these opposing actions, aortic compliance is lower and the fluid volume that can be 
stored in the aortic wall is less than the volume that can be stored when the aorta can freely expand 
during inflation. The fluid volume not stored in the compliant aortic wall in the presence of heart 
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function is then distributed elsewhere (Figures 3 and 4). The discharging of the fluid volume stored in 
the compliant aortic wall is demonstrated in Figure 2A, by the exponential rise in Ptip between 15.5 
and 16.5 s. 
This result underlies in an indirect way the importance of arterial compliance on IABP performance. 
These findings are in agreement with previous studies stating that the efficiency of the IAB is limited 
in highly compliant aortas (20-22).  
The blood volume displaced towards the coronary circulation during the assisted beat of the 1:2 
support is less than the combined volume displaced by two consecutive beats during 1:1 support. 
Although the results are not statistically significantly different for this patient population, it is possible 
that in a larger population differences would be more pronounced. 
Effect of assistance frequency in vivo 
It is expected that the reduction in systolic PLV during 1:1 assistance in patients will induce coronary 
vasoconstriction due to the reduced myocardial oxygen demand (23) and therefore reduce CBF, while 
on the other hand volume displacement due to inflation simultaneously tends to increase it. This 
mechanism could not be duplicated in vitro, and it is difficult to predict how this practically affected 
Vcor. Other in vivo pathological indications for using IABP such as cardiogenic shock and unstable 
refractory angina could not be simulated as their mechanism involve sympathetic and parasympathetic 
nervous activities that couldn’t be replicated in vitro. 
Methodological considerations and limitations 
Conclusions 
The blood volume displaced towards the coronary circulation due to IAB inflation is only a small 
percentage of the nominal IAB volume. However small compared to the IAB volume this percentage 
might be, it is still a significant percentage of baseline coronary perfusion. 
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Tables 
Table 1: Mean volume distribution for the 25 and the 40 cc balloons. 
 
Volume (V, in ml) displaced into the arch and coronary branches and upstream the IAB tip in vitro 
due to IAB inflation at different assistance frequencies, without (‘noHeart’) and with the artificial 
heart (‘Heart’). R, right; L, left. Mean values for the subclavians and the aorta are based on 16 
measurements, while for the other branches 8 measurements were available. *P<0.005, comparing 
‘noHeart’ to ‘Heart’. 
 
 Balloon 25 cc Balloon 40 cc 
                      1:1        1:2A 1:1 1:2A 
V (ml) noHeart Heart noHeart Heart noHeart Heart noHeart Heart 
R subclavian 1.09 ± 0.10* 0.98 ± 0.08 1.02 ± 0.15 1.05 ± 0.17 1.70 ± 0.15 1.62 ± 0.32 1.49 ± 0.16* 2.03 ± 0.31 
L subclavian 1.21 ± 0.12* 0.95 ± 0.19 1.12 ± 0.11* 0.83 ± 0.13 1.79 ± 0.14 1.87 ± 0.39 1.65 ± 0.21 1.57 ± 0.27 
R carotid 0.96 ± 0.03* 3.45 ± 0.06 1.35 ± 0.03* 3.54 ± 0.08 1.54 ± 0.05* 4.13 ± 0.04 1.94 ± 0.12* 4.59 ± 0.06 
L carotid 1.00 ± 0.03* 3.04 ± 0.14 1.55 ± 0.03* 2.98 ± 0.03 1.61 ± 0.05* 3.15 ± 0.08 2.11 ± 0.04* 3.37 ± 0.05 
R coronary 0.47 ± 0.01 0.48 ± 0.01 0.43 ± 0.01* 0.50 ± 0.01 0.90 ± 0.01* 0.82 ± 0.01 0.75 ± 0.01* 0.85 ± 0.01 
L coronary 0.58 ± 0.00* 0.44 ± 0.01 0.56 ± 0.01* 0.44 ± 0.01 0.87 ± 0.02* 0.65 ± 0.01 0.74 ± 0.05* 0.66 ± 0.01 
upstream 17.39 ± 0.92* 15.13 ± 0.89 17.14 ± 1.10* 14.61 ± 0.20 30.22 ± 2.18* 26.25 ± 0.90 27.10 ± 1.45 26.18 ± 0.89 
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Figure Legends 
Figure 1: Hemodynamic waveforms in vivo during 1:2 IABP support for a control (top) and an 
assisted beat (bottom) in two different patients (A and B). Pao, aortic pressure (solid black); Qao, aortic 
flow (filled grey). In cases of correctly-timed inflation, like the one illustrated in A, Vroot was derived 
by subtracting the intrinsic backflow of the control beat from the backflow of the assisted beat (both 
areas shaded in dark grey). In cases of late inflation, like the one in B, Vroot was derived directly from 
the assisted beat, by integrating the area shaded in dark grey. 
Figure 2: Pressure (Ptip, solid black) and flow (Qtip, filled grey) in vitro during 1:2 IABP assistance. 
Arrows indicate the onset of inflation and deflation. No artificial heart was connected to the system in 
A, while the IABP was synchronized to the artificial heart in B. Vtip was derived by integrating the 
area shaded in dark grey in each case. 
Figure 3: Percent distribution of the total volume displaced upstream and downstream a 25 cc IAB 
during inflation at 1:2 assistance, (A) without and (B) with the artificial heart connected to the in vitro 
set up. L, left; R, right. 
Figure 4: Schematic diagram of the upper portion of the artificial aorta, showing the tip of the IAB 
and the approximate locations where flow was measured in the coronary and arch branches. The fluid 
volume that passed trough each branch in vitro due to the inflation of the 40 cc IAB at 1:1 frequency, 
is noted both for the case of no artificial heart connected to the system and with the artificial heart. L, 
left; R, right. 
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Figures 
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Figure 2 
A 
Qtip
Ptip
0
40
80
120
160
P
tip
 (m
m
 H
g)
-15.0
0.0
15.0
Q
tip
 (l
/m
in
)
15.5 16 16.5 17 17.5
time (s)
Without artificial heart
 
B 
0
40
80
120
160
P
tip
 (m
m
 H
g)
-15.0
0.0
15.0
Q
tip
 (l
/m
in
)
16 16.5 17 17.5 18
time (s)
With artificial heart
 
inflation 
deflation 
inflation 
deflation 
  
 19 
Figure 3 
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Figure 4 
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